Georgina Hold obtained her PhD degree from the Division of Infection and Immunity at the University of Glasgow. She is a leading authority on emerging Campylobacter and their role in intestinal disease and in 2014, was awarded a scholarship to Harvard T. H. Chan School of Public Health to study emerging Campylobacter organisms. She currently leads a pioneering Australian IBD Microbiome study looking at how gut microbes, diet and environmental factors affect IBD and IBD treatment responses. Professor Hold is also the president of the European Helicobacter Microbiota Study Group.

Professor of Gut Health, Microbiome Research Centre, UNSW Sydney


GEORGINA HOLD

Session:

CLINICAL PHARMACY UPDATE: Gut health, probiotics and improving immune health - what do we know?

When:

Friday 20 March, 11:00am - 11:30am

Proudly sponsored by:

SESSION SPONSORS

PROGRAM SPONSORS

MAJOR SPONSORS

PRINCIPAL SPONSORS

APP2022 SPONSORS

SESSION SPONSOR

PROGRAM SPONSOR

MAJOR SPONSOR

VIEW ALL

PRINCIPAL SPONSOR

APP2020 SPONSORS

SPONSOR AND TRADE

(c) 2021 APP Conference 2022. All Rights Reserved.

LATEST NEWS

#APP2022

Events Division

The Pharmacy Guild of Australia

Queensland Branch

FOLLOW US

07 3831 9246

SITE CREDITS

CONTACT US

© 2022 APP Conference. All Rights Reserved.

The 2022 Australian Pharmacy Professional Conference is proudly sponsored by:

APP Sand 1

AA8730

APP OCEAN 3

2F7A81

APP OCEAN 2

347D83

GOLD

D3A94A

TEAL 

4AB9B7